Studies of Photosensitivity Due to Sulfanilamide11A preliminary account of these experiments appeared in the Proceedings of the American Physiological Society (Blum, 1940).  by Blum, Harold F.
STUDIES OF PHOTOSENSITIVITY DUE TO
SULFANILAMIDE*
HAROLD F. BLUM, PH.D.f
(Received for publication November 8, 1940)
In the few years during which sulfanilamide therapy has been
practiced numerous instances of abnormal sensitivity to light
have been reported coincident with use of this drug. A review
of these occurrences has recently been presented by Tedder
(1939). Relatively little has been done to ascertain the cause
of such increased photosensitivity with the exception of experi-
ments by Epstein (1939) who found that the response of human
skin to sunlight or mercury arc radiation is increased locally by
the intradermal injection of sulfanilamide, and carried out a
series of very interesting studies of this phenomenon.
The present paper is devoted to further experiments on the
response discovered by Epstein, and an evaluation of its probable
significance with regard to abnormal photosensitivity found
clinically.
EXPERIMENTAL
Responses following irradiation of human skin after intra-
dermal injection of sulfanilamide are shown in figure 1. To
produce them 0.1 cc. of one per cent solution of sulfanilamide in
normal saline was injected intradermally. After about one hour
an area including the site of the injection was subjected to suffi-
cient mercury arc radiation to produce a mild erythema of the
normal unsensitized skin of the subject. An hour or more after
the irradiation (depending upon the dosage of radiation em-
* A preliminary account of these experiments appeared in the Proceedings of
the American Physiological Society (Blum, 1940).
f Research Fellow, National Cancer Institute, National Institute of Health,
United States Public Health Service.
159
160 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
ployed) an erythemal response appeared at the site of the in-
jection which was more intense than that of the surrounding
normal skin. The erythema was followed after some days by
pigmentation, more pronounced in the region of the sulfanilamide
injection than in the surrounding irradiated area. Figure 1
FIG. 1. IRRADIATED AREAS OF SKIN OF THE ABDOMEN
(Photographs reproduced from originals on "Kodachrome" film.)
The areas irradiated are clearly indicated as dark patches; a rectangle below
A, a square below B, and a circular area below C. Small darker areas within
these are sulfanilamide responses at the point of injection.
Area B was irradiated four minutes through a Corex A filter.
Area C was irradiated seven minutes through a Corex D filter.
A triangular area just above C was irradiated for 15 minutes through a window
glass filter. No response was observed.
The photograph was taken a few hours after the irradiation of B and C when
the erythema was near its maximum.
Area A was irradiated seven days previous to the time at which the photograph
was taken. Both the sulfanilamide injected area, and the surrounding irradiated
area showed pigmentation at this time rather than erythema. The photograph
does not distinguish between erythema and pigmentation.
On Area A the sulfanilamide response occurs opposite a. Opposite b an injec-
tion of 0.9 per cent NaCl was made previous to the irradiation. Opposite c,
sulfanilamide was injected immediately after the irradiation. No response
occurred at the site of the latter two injections.
shows examples of both erythema and pigmented stages; in each
case the response at the site of the sulfanilamide injection is
much greater than in the surrounding area.
This series of events, which will be called for convenience the
"sulfanilamide response," seems entirely comparable with that
described by Epstein as occurring in all six subjects used in his
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studies. All the experiments herein described were performed on
a single subject who was much more susceptible than three others
tested, and whose susceptibility seems to have increased during
the course of the experiments. The significance of individual
variations will be discussed later in this paper.
Differences between the sulfanilamide response and photodynamic
action. Epstein terms the response of the type described in
figure 1 "photodynamic," but our experiments indicate that it
is different in nature from the type of effect to which this name is
commonly applied. The term "photodynamic action" should
be used only to describe a type of process in which light is ab-
sorbed by a photosensitizing substance with the result that oxida-
tion by 02 (distinct from normal 02 metabolism) is brought
about. Justification for this definition and evidence that photo-
dynamic action may be regarded as a clear-cut entity is pre-
sented in a recent monograph by the writer (Blum, 1941).
The sulfanilamide response described above is very different
in a number of ways from that obtained when the skin is sub-
jected to photodynamic action. The latter may be readily
obtained by intradermal injection of fluorescent substances,
such as rose bengal, eosin, or hematoporphyrin (see Frei, 1926)
followed by irradiation with wavelengths absorbed by the sub-
stance employed (see Blum, Watrous and West, 1935). Figure
2, a and b, shows the response produced in this way. The typical
photodynamic response is a severe wheal surrounded by a red
flare having all the characteristics generally associated with the
terms "urticaria" or "triple response" whereas the sulfanilamide
response is characterized by erythema without whealing. Thus,
the morphological aspects of the two responses are quite different.
They differ furthermore in their time relationships. The
photodynamic response appears "immediately," that is, within a
few minutes after exposure to light. The wheal may persist for
a few hours, but always disappears within twenty-four; it may be
followed by pigmentation of the site. The sulfanilamide re-
sponse, on the other hand, usually appears after a latent period
of an hour or more, depending, of course, upon the dose of radia-
tion. The erythema persists for some days, being followed by
FIGS. 2a—2d
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pigmentation, and if the dose of radiation is great enough, by
desquamation. In these respects it is similar to the normal
erythema produced by ultraviolet radiation, only quantitative
differences being apparent. Sometimes (see below) there may
be delayed whealing, but this again bears little resemblance to
the photodynamic response.
A third difference between the photodynamic and sulfanilamide
responses is that the former depends upon the presence of 02
whereas the latter, like the normal skin response to ultraviolet
radiation, is independent of 02. Blum, Watrous, and West
(1935) have demonstrated thi difference between the photo-
dynamic and ultraviolet response of skin by showing that oc-
clusion of the circulation with a sphygmomanometer cuff during
FIG. 2. EFFECT OF OccLusIoN OF CIRcUlATIoN DURING IRRADIATION, ON
SULFANILAMIDE AND PHOTODYNAMIC (RosE BENGAL) RESPONSES
The experiment was carried out as follows: Sulfanilamide was injected into
the skin of the inner surfaces of both forearms at 9:15 a.m. At 10:15 a.m. the
circulation was cut off from the left arm by means ofa sphygmomanometer cuff.
At 10:20 a.m. the sites of injection were subjected to mercury arcradiation for
four minutes, after which the blood was allowed to return to the left arm. The
sulfanilamide response appeared on both arms. At 11:20 n.m. 0.1 cc. of 10 M.
rose bengal was injected into normal skin of both arms just below the irradiated
areas. At 12:40 p.m. circulation of the left arm was occluded, and at 12:45 p.m.
both arms were exposed to sunlight for three minutes, after which the blood was
allowed to return to the left arm. The photodynamic response appeared only on
the right arm, which received blood during the irradiation.
2a. Photograph at 1:10 p.m. three hours after the irracliation of the
sulfanilamide injected areas, which now appear as darker spots inside square
areas of less intense erythema. This response was first detectable about one
hour after the irradiation; The photodynamic response appears on the right
forearm just below the sulfanilamide response, as a raised wheal with an irregular
"flare" of erythema surrounding it. The wheal was almost as distinct a few
minutes after the irradiation but the "flare" has increased in diameter dunn
the 25 minutes between irradiation and photograph. No response has occurre
on the left arm from which the circulation was occluded; the point of injection
is marked by a small dark spot which represents the red colored rose bengal
showing through the outer layer of the shin into which it was injected. The
amount of erythema producing radiation in sunlight is so small that no erythema
of the surrounding area was produced by the three-minute exposure.
2b. Photograph 15 minutes later than 2a. The wheal and "flare" of the
photodynamic response is somewhat more diffuse.
2c. Twenty-four hours after the irradiation. The sulfanilamide response is
less distinct because the surrounding erythema was so intense that good contrast
was not obtained in the photograph. The photodynamic wheal has disappeared
leaving a trace of erythema on the right arm.
2d. Eight days later. The sulfanilamide injected areas show strong pigmenta-
tion with beginning desquamation, and are clearly delimited within the square
pigmented areas of the normal skin response. Only a tiny area of pigmentation
marks the site of the photodynamic response on the right arm.
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the irradiation inhibits the photodynamic response, but not the
ultraviolet erythema. The sulfanilamide response like the
normal erythema is not abolished by occlusion of the circulation.'
These facts are illustrated in figure 2. The evidence that photo-
dynamic effects are dependent upon 02, and that the effects of
ultraviolet radiation are not abolished when this factor is re-
moved is discussed by Blum and Spealman (1934), and more
exhaustively by Blum (1941).
These distinct differences between the photodynamic and
sulfanilamide responses show clearly that the latter is not an
example of photodynamic action. On the other hand, the
marked similarity between the behavior of the sulfanilamide
response and the normal skin response to ultraviolet radiation is
strong evidence that these two processes are closely related.
In our experiments, the dosage of radiation was varied in different
ways with corresponding quantitative variations in the response
of the sulfanilamide-treated skin, and in that of the normal
surrounding skin. These variations were always parallel; the
erythema always appeared somewhat earlier at the site of the
sulfanilamide injection than on the surro3inding area, and the
whole response including pigmentation ran a more severe course.
Desquamation sometimes occurred over the site of injection when
it did not occur on the surrounding area, but this was obviously
a quantitative rather than a qualitative difference. In certain
experiments more severe reactions occurred which will be clis-
cussed below.
It should be emphasized that the question involved is not
merely one of nomenclature, but of fundamental mechanism.
Many substances produce the photodynamic response (see
Frei, 1926, Blum, 1941) but responses of the sulfanilamide
type do not appear to have been observed for other compounds.
The active wavelengths. The observatiotis just described suggest
that the sulfanilamide response represents an enhancement
of the sensitivity of normal epidermal cells to ultraviolet radia-
tion in which case the wavelengths producing the sulfanilamide
response should be the same as those which elicit the ultraviolet
1 This observation was confirmed on a second subject.
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response of normal skin. If the response resulted from an ex-
traneous photochemical reaction in which sulfanilamide was the
radiation-absorbing substance, only those wavelengths absorbed
by the sulfanilamide should be effective.
Figure 3 shows the action spectrum for normal erythema of
human skin, i.e., the relative effectiveness of various wave-
lengths in producing this response, and the absorption spectrum
FIG. 3. CHART OP SPECTRAL REGIoNS
The ordinates are arbitrarily chosen and not quantitatively comparable.
The curves are labelled as follows:
Erythema: The action spectrum for production of erythema in normal human
skin. The ordinate values are reciprocals of the energy required to produce
minimal erythema.
Sulfanilamide and Hematoporphyrin: Absorption spectra of these compounds.
10Ordinate values are absorption coefficients (log
Corex A, Corex D, Pyrex, and Window Glass: Transmission of these filters
in the region of their short wavelength cutoffs. Ordinate values are percentage
transmission.
The vertical lines indicate the wavelengths and relative intensities emitted
by a "therapeutic type" mercury arc such as was used in these experiments.
of sulfanilamide. Also shown are the positions and relative
magnitude of the lines of a mercury arc such as was the source
of the exciting radiation in the present studies, and the spectral
transmission of the four filters which were used to delimit spectral
regions, namely, window glass, Corex A, Corex D, and Pyrex.
Window glass cuts out virtually all those wavelengths which
produce erythema (i.e., wavelengths shorter than 3200 A) and
2500 3000 .3500 4000
Wave-/.ngths — A.
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those which are absorbed by sulfanilamide as well. Neither the
sulfanilamide response nor normal erythema were produced
when this filter was interposed between the source and the skin.
When the three other filters were used, the dosage of radiation
was always adjusted so that a mild erythema of the untreated
area was produced, no attempt being made to obtain exactly
the same degree of response in each case. In all instances the
intensity of the sulfanilamide response was affected to the same
degree as the normal response, indicating that the action spectrum
is the same for both.
This would seem to rule out the possibility that the sulfanil-
amide itself is activated by light, but this conclusion should not
be too readily accepted. The action spectrum for the normal
erythema of sunburn must be greatly influenced by the light-
absorbing properties of the stratum corneum. It is probable that
the light-absorbing substance for the erythema mechanism is the
protein constituent of the stratum germinativum of the epidermis
whose maximum absorption is at shorter wavelengths than the
maximum of the action spectrum for erythema, the latter being
shifted by the filtering action of the corneum (see Mitchell,
1938; Blum, 1941). The light-absorbing substance may be the
nucleic acid constituent rather than protein, but the argument
would apply equally well in that case. The absorption spectrum
of sulfanilamide is similar enough to the absorption spectra of
the ring containing proteins and of nucleic acids that a correspond-
ing shift in the maximum of the action spectrum might be ex-
pected, and hence the possibility that sulfanilamide is the light
absorber in the response under consideration cannot be excluded
on the basis of these experiments alone. More exact studies
using monochromatic light might help to decide this question,
but the complex nature of the system, the resemblance between
the absorption spectra of the suspected substances, and the
relatively narrow spectral region involved make it doubtful that
such studies would yield more conclusive results than the crude
experiments herein described.
These experiments rule out one mechanism which has been sug-
gested, namely, photosensitization by porphyrins. Rimington
and Hemmings (1938) found increased porphyrin excretion by
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animals fed sulfanilamide, and suggested that the porphyrins
act as photosensitizers in such instances. If this were the case,
the sulfanilamide response should be produced by those wave-
lengths absorbed by porphyrins. All porphyrins show a great
maximum of absorption in the neighborhood of 3800A. The
absorption spectrum for hematoporphyrin shown in figure 3
is a typical example illustrating this. Reference to that figure
shows that photosensitivity due to porphyrins should be elicited
by wavelengths which are transmitted by window glass, whereas
this filter prevents the sulfanilamide response. Blum and Pace
(1937) have shown that photosensitization by porphyrins is
difficult to elicit with the mercury arc although easily produced
by sunlight or the carbon arc because of the great difference
in spectral distribution of the radiation from these sources.
Unless radiation shorter than 3300A is excluded when the mercury
arc is used, intense sunburn will be produced by dosages which
are not sufficient to elicit photodynamic response with hema-
toporphyrin. Thus Rimington and Hemmings' observation
(1938) that sulfanilamide-treated rats appeared more sensitive
to mercury arc radiation than untreated controls suggests that
they were hypersensitive to the spectral region of the normal
erythema response, rather than that porphyrins were acting as
photosensitizers.
If clinical photosensitivity following sulfanilamide therapy
results from the same mechanism which produces the responses
described in this paper, both must be elicited by the same wave-
lengths. We have seen above that the wavelengths producing
the experimental response are limited to a region shorter than
about 3200A, e.g., the full mercury arc spectrum is effective, but
not when wavelengths shorter than this limit are removed by
window glass (see fig. 3). Unfortunately the same experiment
has not been tried in clinical cases. In some instances it is re-
ported that the lesions were reproduced by irradiating areas not
previously exposed. Newman and Sharlit (1937) and Brunsting
(1937) state that this was accomplished with "ultraviolet"
irradiation but do not describe the source. The former also
produced the response with sunlight.
Epstein (see discussion of Tedder 1939) describes a case in
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which the patient responded to sunlight passing through window
glass. This does not necessarily mean that the patient was
sensitive to wavelengths longer than those which produce er-
ythema of normal skin and the experimental sulfanilamide re-
sponse. Reference to figure 3 shows that window glass transmits
a small amount of erythema-producing radiation, i.e., between
3150 and 3300A, and in this region sunlight is much more intense
than mercury arc radiation, which is only represented by a weak
line at 3341A. Normal skin shows no erythema following ex-
posure to sunlight passing through window glass,2 but a hyper-
sensitive skin might respond to this radiation.
Sulfanilamide in previously irradiated skin..—W hen sulfanil-
amide is injected into an irradiated area immediately after the
irradiation, the course of the erythema is not affected. This was
observed by Epstein, and has been confirmed by the writer (see
fig. 1). Thus the drug does not enhance effects which result
from exposure of normal skin to ultraviolet radiation. For
example, it does not act by increasing the response of the minute
blood vessels of the skin to dilator substances elaborated by the
epidermis as a result of irradiation. The sulfanilamide must
from this evidence act simultaneously with the radiation or by
its previous action increase the susceptibility of the epidermis to
radiation.
Injection of previously irradiated sulfanilamide 8OlutiOfl. None
of the evidence presented above completely rules out the possi-
bility that the sulfanilamide response results from the photo-
chemical transformation of sulfanilamide within the skin. Sul-
fanilamide is altered by irradiation in vitro. At least two colored
products, one blue and one brown, are formed, and under some
conditions these changes occur rapidly enough to account, con-
ceivably, for the sulfanilamide response. A number of factors
are important in determining whether the blue or the brown prod-
uct predominates, including the concentration and thickness of
the sulfanilamide solution, intensity of radiation, and hydrogen-
ion concentration (see Fox, Cline, and Ottenburg (1939)).
2 However, a pigment effect may be observed (see Henscke and Schultze
(1939a, b) and Miescher and Minder (1939) or the discussion by Blum (1940b)).
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An attempt to produce the sulfanilamide reaction by injecting
previously irradiated solutions is an obvious experimental pro-
cedure. However, it is impossible to duplicate in vitro the condi-
tions of irradiation of the skin with regard to the various factors
which control the rate of formation and relative concentrations
of the end products. Thus negative results caunot be accepted
as conclusive evidence.
Epstein found that previously irradiated sulfanilamide solu-
tions (some with blood serum) did not produce the sulfanilamide
response when injected intradermally. I have irradiated sul-
fanilamide in various buffered solutions (pH 5.8 to 7.4) for differ-
ent periods without obtaining upon intradermal injection any
response greater than that produced by the injection of the buffer
solutions themselves. Some of the solutions injected were blue,
some brown, so that different proportions of end products were
represented.
Change in response following repeated injections and irradiations.
Epstein found that in two of six subjects the suifanilamide re-
sponse of the type described above was followed on the tenth day
by a secondary inflammatory, urticarial reaction at the same site
accompanied by intense pruritis. In subsequent experiments,
these individuals developed the inflammatory type of response
much earlier and showed other evidence of increased sensitivity.
This he called "photoallergic response."
The principal subject in the above studies developed a reaction
of essentially the same type after a few experiments had been
carried out. It was, however, less distinctly separable from the
primary response than in the instances described by Epstein.
It was entirely absent from the first experiments, only appearing
after the fourth, in which the primary reaction developed into an
inflammatory itching wheal some hours after the irradiation. In
isolated experiments performed three and six months after the
first series, the same inflammatory response was observed. In
the latter instance a relatively intense inflammatory reaction
was produced by a dose of radiation which caused only a barely
detectable erythema of the normal surrounding skin. As in
previous instances, injection of sulfanilamide not followed by
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irradiation produced no abnormal response. Three other sub-
jects showed much less definite primary reactions, and never
displayed the secondary inflammatory response. Repeated
experiments were not carried out on these subjects.
Animal experiments. Attempts were made to reproduce the
suffanilamide response in rats, guinea pigs, and rabbits, but
without success. Attempts to sensitize rabbits and rats by re-
peated injections and irradiations were unsuccessful.
DISCUSSION
In addition to the numerous cases of photosensitivity due to
sulfanilamide a few have been reported in association with closely
related drugs. Hallam (1939) reports a case in which exposure to
mercury arc radiation following administration of sulfapyridine
(M and B 693) resulted in severe inflammatory reaction of the
skin, and Sehölzke (1938) and Grave (1939) describe increased
sensitivity to sunlight coincident with the use of Suiphanilyl
Dimethyl Sulfanilamide (Uliron) . Thus it seems probable
that all members of this group of drugs are capable of producing
photosensitivity, presumably of the type associated with sul-
fanilamide.
On the other hand, considerable numbers of patients have
been exposed to radiation in conjunction with the administration
of such drugs without the appearance of photosensitivity. Snod-
grass and Anderson (1937) combined ultraviolet radiation therapy
with the use of prontosil without observing untoward effects.
Schölzke (1938) examined the sensitivity of 40 patients treated
with Uliron, exposing them to either mercury arc, sunlight, or
carbon arc radiation, but found no evidence of photosensitivity.
Eidinow (1939) treated patients with prontosil or with sul-
phanilamide ("sulfonamide F") and exposed them to carbon arc,
tungsten arc, or sunlight, but found no abnormal sensitivity to
the radiation from these sources.
There appears to be a discrepancy between such experimental
studies and the clinical findings, and one can only conclude
that while photosensitivity is occasionally associated with the
See Long and Bliss (1939) for the nomenclature of these drugs.
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clinical use of sulfanilamide or similar compounds, this is not a
regular occurrence.
The present studies together with those of Epstein may explain
this apparent discrepancy. They show that sulfanilarnide in-
creases the photosensitivity of normal human skin if present in
sufficiently high concentration, as this has been observed in all
the individuals tested (Epstein 6, Blum 4). However, the con-
centration of the drug injected into the skin in these experiments
seems much greater than would be reached when the drug is
administered therapeutically, so that it is not surprising that
photosensitivity was not observed in the clinical studies cited
above. The sporadic clinical occurrence of photosensitivity
may find its explanation in the fact that the sensitivity of certain
individuals is increased by repeated injections and irradiations.
It seems possible that such sensitization may occur in a relatively
large number of individuals since it was found in three of a total
of 10 cases studied (Epstein 2, Blum 1).
While this information does not permit definite conclusions as
to the importance of photosensitivity caused by the sulfanilamide
drugs, it should constitute a warning against the exposure of
patients treated with these compounds to sunlight, or to other
sources of ultraviolet radiation such as the common therapeutic
mercury or carbon arcs. Although it is apparent that the major-
ity of individuals do not display appreciable photosensitivity
upon a single exposure to such radiation during the course of
sulfanilamide therapy, at least a certain number might be ex-
pected to develop photosensitivity after repeated adminiRtration
of these drugs accompanied by such exposure.
The possibility that such effects may occur in a relatively large
number of individuals ii repeatedly exposed during sulfanilamide
therapy, and the severity of those cases which have been re-
ported, would suggest that patients be kept from direct exposure
to sunlight or therapeutic lamps during the period of sulfanil-
amide therapy, and perhaps for some time afterward. Use of
these drugs on ambulatory patients would seem particularly
dangerous because of the repeated exposure to sunlight, and this
danger may be reason for restricting their sale without prescrip-
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tion of a physician. Exposure to sunlight through window glass
should be relatively safe (but see above), so that there should
be little danger from ordinary exposure in a hospital ward if the
patient is not placed directly in front of an open window.
it seems advisable that a more careful study of photosensitivity
be made where patients are being subjected to therapy with
these drugs, particularly as regards the effect of repeated ir-
radiations during the course of treatment.
SUMMARY
Sulfanilamide in high concentration sensitizes human skin to
ultraviolet radiation of wavelengths shorter than 3200A produc-
ing a response similar to severe sunburn.
This is not an example of photodynamic action.
Porphyrin are not concerned in this response.
The response probably represents an increased sensitivity of
the sunburn mechanism of normal skin.
In some individuals an inflammatory reaction follows repeated
intradermal injection of the drug accompanied by irradiation.
Patients should not be exposed to direct sunlight or to mercury
or carbon arcs during treatment with sulfanilamide or related
drugs, since occasional individuals may develop untoward re-
actions or become sensitized in the course of treatment.
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